Pharmacotherapy of HTN Flashcards
Epidemiology of HTN
1/3 adults in US have HTN
About 70% of people with MI, CVA, or heart failure have BP >140/90
Normal BP
<120/80
Pre-HTN
120-139/80-89
Stage 1 HTN
140-159/90-99
Stage 2 HTN
>160/100
CVD risk doubles with what increase in BP?
20/10
Evaluation of elevated BP
- Asses lifestyle and identify other CV RFs or concomitant disorders
- Reveal identifiable causes of high BP (primary vs secondary HTN)
- Asses the presence or absence of target organ damage
JNC 7 Major Cardiovascular Disease RFs
HTN
Tobacco Use
Obesity
Physical inactivity
DM
Dyslipidemia
Microalbuminuria
Age (55/65)
FHx of premature CVD (MI/sudden death)– 55/65
Definable causes of HTN
(secondary HTN)
Sleep apnea
Chronic kidney disease
Primary aldosteronism
Renovascular disease
Chronic steroid therapy/Cushings syndrome
Pheochromocytoma
Coarctation of the aorta
Thyroid or parathyroid disease
Medications that can cause HTN
NSAIDs
Corticosteroids
Oral contraceptives
Cocaine, amphetamines
Sympathomimetics
Erythropoieten
Licorice
Target Organ Damage
Heart: LV hypertrophy, angina or prior MI, prior coronary revascularization, heart failure
Brain: stroke/TIA
Nephropathy
Peripheral artery disease
Retinopathy
Goal of HTN therapy
Reduce CVD and renal morbidity and mortality
Achieve SBP goal
Blood pressure goals for uncomplicated HTN
<140/90
Blood pressure goals if also have DM, renal disease, CAD, CAD equivalents, Framingham score >10%, or left ventricular heart failure
<130/80
The Big 5: Lifestyle Modifications to Manage HTN
- Weight reduction
- DASH diet
- Decrease Sodium intake
- Physical activity
- Moderation of alcohol consumption
Pharm treatment decreases the risk of what?
clearly decreases the incidence of cardiovascular morbidity and mortality
Dec BP by 5-6 leads to 42% dec in stroke and 14% in CHD